Is Reviva Pharmaceuticals Stock a Good Investment?
Reviva Pharmaceuticals Investment Advice | RVPHW |
- Examine Reviva Pharmaceuticals' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Reviva Pharmaceuticals' leadership team and their track record. Good management can help Reviva Pharmaceuticals navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Reviva Pharmaceuticals' business and its evolving consumer preferences.
- Compare Reviva Pharmaceuticals' performance and market position to its competitors. Analyze how Reviva Pharmaceuticals is positioned in terms of product offerings, innovation, and market share.
- Check if Reviva Pharmaceuticals pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Reviva Pharmaceuticals' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Reviva Pharmaceuticals Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Reviva Pharmaceuticals Holdings is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Reviva Pharmaceuticals Stock
Researching Reviva Pharmaceuticals' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if Reviva Pharmaceuticals is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Reviva Pharmaceuticals' research are outlined below:
| Reviva Pharmaceuticals generated a negative expected return over the last 90 days | |
| Reviva Pharmaceuticals has high historical volatility and very poor performance | |
| Reviva Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Reviva Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company has accumulated 4.83 M in total debt. Reviva Pharmaceuticals has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Reviva Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Reviva Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Reviva Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Reviva to invest in growth at high rates of return. When we think about Reviva Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (39.26 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Reviva Pharmaceuticals Holdings has accumulated about 353.26 K in cash with (28.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Reviva Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Reviva Pharmaceuticals Operational Performance Insights - TipRanks.com - TipRanks |
Reviva Pharmaceuticals Quarterly Cost Of Revenue |
|
Reviva Pharmaceuticals' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 85.81 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Reviva Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Reviva Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Reviva Pharmaceuticals' profitablity analysis
Reviva Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Reviva Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Reviva Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Reviva Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Reviva Pharmaceuticals' profitability requires more research than a typical breakdown of Reviva Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.16) | (1.22) | |
| Return On Capital Employed | (2.17) | (2.06) | |
| Return On Assets | (1.16) | (1.22) | |
| Return On Equity | (2.27) | (2.16) |
Determining Reviva Pharmaceuticals' profitability involves analyzing its financial statements and using various financial metrics to determine if Reviva Pharmaceuticals is a good buy. For example, gross profit margin measures Reviva Pharmaceuticals' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Reviva Pharmaceuticals' profitability and make more informed investment decisions.
The data published in Reviva Pharmaceuticals' official financial statements usually reflect Reviva Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Reviva Pharmaceuticals. For example, before you start analyzing numbers published by Reviva accountants, it's critical to develop an understanding of what Reviva Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Reviva Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Reviva Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Reviva Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Reviva Pharmaceuticals Holdings. Please utilize our Beneish M Score to check the likelihood of Reviva Pharmaceuticals' management manipulating its earnings.
Evaluate Reviva Pharmaceuticals' management efficiency
Reviva Pharmaceuticals has return on total asset (ROA) of (1.1585) % which means that it has lost $1.1585 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (5.5638) %, meaning that it generated substantial loss on money invested by shareholders. Reviva Pharmaceuticals' management efficiency ratios could be used to measure how well Reviva Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.22 in 2024. Return On Capital Employed is likely to climb to -2.06 in 2024. At this time, Reviva Pharmaceuticals' Other Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 504.5 K in 2024, whereas Total Assets are likely to drop slightly above 18.2 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.57 | 0.50 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 0.57 | 0.50 | |
| Enterprise Value Over EBITDA | (2.40) | (2.52) | |
| Price Book Value Ratio | 6.06 | 6.36 | |
| Enterprise Value Multiple | (2.40) | (2.52) | |
| Price Fair Value | 6.06 | 6.36 | |
| Enterprise Value | 58 M | 60.9 M |
The analysis of Reviva Pharmaceuticals' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Reviva Pharmaceuticals' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Reviva Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 0.047 |
Basic technical analysis of Reviva Stock
As of the 30th of May, Reviva Pharmaceuticals holds the Variance of 161.07, risk adjusted performance of (0.03), and Coefficient Of Variation of (1,471). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Reviva Pharmaceuticals, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We have analyze and collected data for thirteen technical drivers for Reviva Pharmaceuticals, which can be compared to its competitors. Please check Reviva Pharmaceuticals risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and kurtosis to decide if Reviva Pharmaceuticals is priced some-what accurately, providing market reflects its current price of 0.3 per share. As Reviva Pharmaceuticals appears to be a penny stock we also advise to check out its jensen alpha numbers.Reviva Pharmaceuticals' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Reviva Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Reviva Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Reviva Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Laxminarayan Bhat over a month ago Acquisition by Laxminarayan Bhat of 443000 shares of Reviva Pharmaceuticals at 6.74 subject to Rule 16b-3 | ||
Saxena Parag over two months ago Acquisition by Saxena Parag of 4000 shares of Reviva Pharmaceuticals at 4.73 subject to Rule 16b-3 |
Understand Reviva Pharmaceuticals' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Reviva Pharmaceuticals' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 0.3558 | |||
| Mean Deviation | 8.55 | |||
| Coefficient Of Variation | (1,471) | |||
| Standard Deviation | 12.69 | |||
| Variance | 161.07 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.41) | |||
| Treynor Ratio | 0.3458 | |||
| Maximum Drawdown | 72.77 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 18.97 | |||
| Skewness | 0.5282 | |||
| Kurtosis | 4.13 |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 0.3558 | |||
| Mean Deviation | 8.55 | |||
| Coefficient Of Variation | (1,471) | |||
| Standard Deviation | 12.69 | |||
| Variance | 161.07 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.41) | |||
| Treynor Ratio | 0.3458 | |||
| Maximum Drawdown | 72.77 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 18.97 | |||
| Skewness | 0.5282 | |||
| Kurtosis | 4.13 |
Consider Reviva Pharmaceuticals' intraday indicators
Reviva Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Reviva Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Reviva Pharmaceuticals time-series forecasting models is one of many Reviva Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Reviva Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Reviva Stock media impact
Far too much social signal, news, headlines, and media speculation about Reviva Pharmaceuticals that are available to investors today. That information is available publicly through Reviva media outlets and privately through word of mouth or via Reviva internal channels. However, regardless of the origin, that massive amount of Reviva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Reviva Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Reviva Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Reviva Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Reviva Pharmaceuticals alpha.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Reviva Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
How to buy Reviva Stock?
To provide specific investment advice or recommendations on Reviva Pharmaceuticals Holdings stock, we recommend investors consider the following general factors when evaluating Reviva Pharmaceuticals Holdings. This will help you to make an informed decision on whether to include Reviva Pharmaceuticals in one of your diversified portfolios:- Examine Reviva Pharmaceuticals' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Reviva Pharmaceuticals' leadership team and their track record. Good management can help Reviva Pharmaceuticals navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Reviva Pharmaceuticals' business and its evolving consumer preferences.
- Compare Reviva Pharmaceuticals' performance and market position to its competitors. Analyze how Reviva Pharmaceuticals is positioned in terms of product offerings, innovation, and market share.
- Check if Reviva Pharmaceuticals pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Reviva Pharmaceuticals' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Reviva Pharmaceuticals Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Reviva Pharmaceuticals Holdings is a good investment.
Already Invested in Reviva Pharmaceuticals Holdings?
The danger of trading Reviva Pharmaceuticals Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Reviva Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Reviva Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Reviva Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Reviva Pharmaceuticals information on this page should be used as a complementary analysis to other Reviva Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Reviva Stock analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets |
Is Reviva Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (1.16) | Return On Equity (5.56) |
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Reviva Pharmaceuticals' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.